Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome
- 9 August 2011
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 28 (3) , 190-194
Abstract
Polycystic ovary syndrome (PCOS) is an endocrinopathy associated with infertility, diabetes and cardiovascular events. This study aimed to correlate polymorphisms of genes involved in the biosynthesis and metabolism of steroids and insulin action (CYP17A1, CYP19A1, AR, ESR1, ESR2, INSR, IGF2 and PAI1) with clinical and biochemical parameters of PCOS. DNA was extracted from peripheral blood samples obtained from 117 PCOS and 105 healthy women. The PAI1 insertion/deletion (-675 ins/delG) polymorphism (rs1799768) was genotyped by PCR-SSCP. CYP19A1 [TTTA]n, AR [CAG]n, ESR1 [TA]n, and ESR2 [CA]n genes were evaluated by PCR-based GeneScan analysis, while CYP17A1 5′UTR (rs743572), INSR 1058 CT (rs1799817), and IGF2 3′UTR GA (rs680) polymorphisms were evaluated by PCR-RFLP. The results showed a prevalence of PAI1 4G5G+4G4G genotypes in PCOS (p = 0.025). Younger PCOS women showed a predominance of CT+TT, GA+AA and 4G5G+4G4G genotypes of INSR, IGF2, and PAI1 (p = 0.0499, p = 0.0300, p = 0.0350, respectively). AR shorter alleles (≤ 20 repeats) were significantly associated with higher serum levels of total testosterone (TT, p = 0.0086). In conclusion, PAI1 polymorphism seems to be associated with the risk of PCOS development. Younger PCOS women had specific genotypes of INSR, IGF2 and PAI1 genes. AR shorter alleles can be associated with higher serum levels of TT in PCOS patients.Keywords
This publication has 26 references indexed in Scilit:
- Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventionsFertility and Sterility, 2010
- CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE ReviewAmerican Journal of Epidemiology, 2004
- The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levelsEuropean Journal of Endocrinology, 2004
- Association of the Polycystic Ovary Syndrome with Genomic Variants Related to Insulin Resistance, Type 2 Diabetes Mellitus, and ObesityThe Journal of Clinical Endocrinology & Metabolism, 2004
- Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and PitfallsObstetrical & Gynecological Survey, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- Androgen Receptor Gene CAG Repeat Polymorphism in the Development of Ovarian HyperandrogenismThe Journal of Clinical Endocrinology & Metabolism, 2003
- A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndromeFertility and Sterility, 2002
- Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunctionAmerican Journal of Medical Genetics, 1999
- Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.Proceedings of the National Academy of Sciences, 1993